Why UK Employers Need a Medical Cannabis Policy
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
24 results for “uk”
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Two years on from the legalisation of medical cannabis in Ukraine, patients have received the first legal prescriptions for cannabis-based medicines.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
The National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
A quick rundown of the highlights so far, and what’s still left to look forward to.
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still […]
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers […]
What was once hailed as a historic victory has become a ‘national failure’, campaigners say.
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) […]
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.